Markus WEIGANDT

Person

Mannheim, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Pharmaceutical formulation
- Patent number 11,559,490
- Issue date Jan 24, 2023
- Merck Patent GmbH
- Simon Geissler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical preparation
- Patent number 11,478,459
- Issue date Oct 25, 2022
- Merck Patent GmbH
- Simon Geissler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aqueous pharmaceutical formulation comprising anti-PD-L1 antibody A...
- Patent number 11,058,769
- Issue date Jul 13, 2021
- Merck Patent GmbH
- Gianluca Rinaldi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Preparation of nanoparticles-releasing enteric microparticles
- Patent number 10,561,622
- Issue date Feb 18, 2020
- Merck Patent GmbH
- Andrea Hanefeld
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for producing nanoparticles laden with active ingredient
- Patent number 10,561,733
- Issue date Feb 18, 2020
- Merck Patent GmbH
- Markus Weigandt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigen-loaded chitosan nanoparticles for immunotherapy
- Patent number 10,369,217
- Issue date Aug 6, 2019
- Merck Patent GmbH
- Andrea Hanefeld
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Silicon dioxide nanoparticles and the use thereof for vaccination
- Patent number 10,111,952
- Issue date Oct 30, 2018
- Merck Patent GmbH
- Markus Weigandt
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Silicon dioxide nanoparticles and the use thereof for vaccination
- Patent number 9,808,521
- Issue date Nov 7, 2017
- Merck Patent GmbH
- Markus Weigandt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Silicon dioxide nanoparticles and the use thereof for vaccination
- Patent number 9,433,673
- Issue date Sep 6, 2016
- Merck Patent GmbH
- Markus Weigandt
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Silicon dioxide nanoparticles and the use thereof for vaccination
- Patent number 8,980,324
- Issue date Mar 17, 2015
- Merck Patent GmbH
- Markus Weigandt
- B82 - NANO-TECHNOLOGY

Patents Applicationslast 30 patents

Information Patent Application
PHARMACEUTICAL FORMULATION
- Publication number 20240408021
- Publication date Dec 12, 2024
- Merck Patent GmbH
- Simon Geissler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL FORMULATION
- Publication number 20230119567
- Publication date Apr 20, 2023
- Merck Patent GmbH
- Simon Geissler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IGG:TGFBETARII FUSION PROTEIN COMPOSITION
- Publication number 20230043290
- Publication date Feb 9, 2023
- Ares Trading S.A
- Chiara IORIO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL PREPARATION
- Publication number 20220288068
- Publication date Sep 15, 2022
- Merck Patent GmbH
- Corinna SCHOCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AQUEOUS PHARMACEUTICAL FORMULATION COMPRISING ANTI-PD-L1 ANTIBODY A...
- Publication number 20210100903
- Publication date Apr 8, 2021
- Merck Patent GmbH
- Gianluca RINALDI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical formulation
- Publication number 20210085611
- Publication date Mar 25, 2021
- Merck Patent GmbH
- Simon GEISSLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL PREPARATION
- Publication number 20200237733
- Publication date Jul 30, 2020
- Merck Patent GmbH
- Simon GEISSLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AQUEOUS PHARMACEUTICAL FORMULATION COMPRISING ANTI-PD-L1 ANTIBODY A...
- Publication number 20180369377
- Publication date Dec 27, 2018
- Merck Patent GmbH
- Gianluca RINALDI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SILICON DIOXIDE NANOPARTICLES AND THE USE THEREOF FOR VACCINATION
- Publication number 20180071386
- Publication date Mar 15, 2018
- Merck Patent GmbH
- Markus Weigandt
- B82 - NANO-TECHNOLOGY
Information Patent Application
PREPARATION OF NANOPARTICLES-RELEASING ENTERIC MICROPARTICLES
- Publication number 20170312229
- Publication date Nov 2, 2017
- Merck Patent GmbH
- Andrea HANEFELD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIGEN-LOADED CHITOSAN NANOPARTICLES FOR IMMUNOTHERAPY
- Publication number 20170143822
- Publication date May 25, 2017
- Merck Patent GmbH
- Andrea HANEFELD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SILICON DIOXIDE NANOPARTICLES AND THE USE THEREOF FOR VACCINATION
- Publication number 20160303228
- Publication date Oct 20, 2016
- Merck Patent GmbH
- Markus Weigandt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Survivin-Directed Cancer Vaccine Therapy
- Publication number 20160279213
- Publication date Sep 29, 2016
- Merck Patent GmbH
- Simon Geissler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SILICON DIOXIDE NANOPARTICLES AND THE USE THEREOF FOR VACCINATION
- Publication number 20150224189
- Publication date Aug 13, 2015
- Merck Patent GmbH
- Markus Weigandt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR PRODUCING NANOPARTICLES LADEN WITH ACTIVE INGREDIENT
- Publication number 20150051181
- Publication date Feb 19, 2015
- Merck Patent GmbH
- Markus Weigandt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SILICON DIOXIDE NANOPARTICLES AND THE USE THEREOF FOR VACCINATION
- Publication number 20110123620
- Publication date May 26, 2011
- Merck Patent Gesellschaft mit Beschrankter Haftung
- Markus Weigandt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Markus WEIGANDT

Person

Patents Grantslast 30 patents

Pharmaceutical formulation

Pharmaceutical preparation

Aqueous pharmaceutical formulation comprising anti-PD-L1 antibody A...

Preparation of nanoparticles-releasing enteric microparticles

Process for producing nanoparticles laden with active ingredient

Antigen-loaded chitosan nanoparticles for immunotherapy

Silicon dioxide nanoparticles and the use thereof for vaccination

Silicon dioxide nanoparticles and the use thereof for vaccination

Silicon dioxide nanoparticles and the use thereof for vaccination

Silicon dioxide nanoparticles and the use thereof for vaccination

Patents Applicationslast 30 patents

PHARMACEUTICAL FORMULATION

PHARMACEUTICAL FORMULATION

IGG:TGFBETARII FUSION PROTEIN COMPOSITION

PHARMACEUTICAL PREPARATION

AQUEOUS PHARMACEUTICAL FORMULATION COMPRISING ANTI-PD-L1 ANTIBODY A...

Pharmaceutical formulation

PHARMACEUTICAL PREPARATION

AQUEOUS PHARMACEUTICAL FORMULATION COMPRISING ANTI-PD-L1 ANTIBODY A...

SILICON DIOXIDE NANOPARTICLES AND THE USE THEREOF FOR VACCINATION

PREPARATION OF NANOPARTICLES-RELEASING ENTERIC MICROPARTICLES

ANTIGEN-LOADED CHITOSAN NANOPARTICLES FOR IMMUNOTHERAPY

SILICON DIOXIDE NANOPARTICLES AND THE USE THEREOF FOR VACCINATION

Survivin-Directed Cancer Vaccine Therapy

SILICON DIOXIDE NANOPARTICLES AND THE USE THEREOF FOR VACCINATION

PROCESS FOR PRODUCING NANOPARTICLES LADEN WITH ACTIVE INGREDIENT

SILICON DIOXIDE NANOPARTICLES AND THE USE THEREOF FOR VACCINATION